norelgestromin has been researched along with ethisterone in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 39 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, LS; Anderson, NJ; Leese, PT; Skee, DM; Wong, FA | 1 |
Abrams, LS; Creasy, GW; Fisher, AC | 1 |
Abrams, LS; Creasy, GW; Leese, PT; Natarajan, J; Shangold, MM; Skee, DM; Wong, FA | 1 |
Zieman, M | 1 |
Abrams, LS; Natarajan, J; Skee, D; Wong, FA | 1 |
Creasy, GW; Fisher, AC; Guillebaud, J; Shangold, GA; Weisberg, E; Zieman, M | 1 |
Creasy, GW; Fisher, AC; Meador, ML; Odlind, V; Shangold, GA; Sibai, BM | 1 |
Archer, DF; Bigrigg, A; Creasy, GW; Fisher, AC; Shangold, GA; Smallwood, GH | 1 |
Creasy, GW; Fisher, AC; Hedon, B; Mansour, D; Shangold, GA; Zacur, HA | 1 |
Abrams, LS; Anderson, GD; Natarajan, J; Skee, DM; Wong, FA | 1 |
Abrams, LS; Allen, JG; Creasy, GW; Hammond, GL; Natarajan, J; Siiteri, PK | 1 |
Sicat, BL | 1 |
Creasy, GW; Fisher, AC; Hall, N; Shangold, GA | 1 |
Caubel, P; Chetrite, GS; Friedman, AJ; Pasqualini, JR; Philippe, JC | 1 |
Archer, DF; Creasy, GW; Fisher, AC; Moreau, M; Pierson, RA; Shangold, GA | 1 |
Hussar, D | 1 |
Henzl, MR; Loomba, PK | 1 |
Fanta, M | 1 |
Evans, SL; Forinash, AB | 1 |
Gaspard, U | 1 |
Halpern-Felsher, BL; Irwin, CE; Rubinstein, ML | 1 |
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T; Zhong, G | 1 |
Logsdon, S; Omar, HA; Richards, J | 1 |
Dikov, I; Ivanov, S; Sigridov, I | 1 |
Lidegaard, O | 1 |
Levine, JP | 1 |
Lelle, I; Prifti, S; Rabe, T; Strowitzki, T | 1 |
Dunn, K; Flanagan, P; Harel, D; Harel, Z; Riggs, S; Vaz, R | 1 |
Fisher, AC; Friedman, AJ; Karvois, DL; Kaunitz, AM; Laguardia, KD; Stewart, FH | 1 |
Audet, MC; Bouchard, C; Dattani, D; Dinniwell, J; Horbay, GL; Mawdsley, S; Moreau, M; Weisberg, F | 1 |
Bainbridge, JD; Fisher, AC; Friedman, AJ; LaGuardia, KD; LoCoco, JM | 1 |
Easthope, SE; Goa, KL; Warner, GT | 1 |
Jain, JK; Stanczyk, FZ; White, T | 1 |
Wooltorton, E | 1 |
Atreja, A; Falcone, T; Harris, CM; Jain, A; Thacker, HL | 1 |
Radowicki, S; Skórzewska, K; Szlendak, K | 1 |
Szarewski, A | 1 |
12 review(s) available for norelgestromin and ethisterone
Article | Year |
---|---|
Transdermal contraception.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Drug Implants; Drug Interactions; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Pregnancy; Safety | 2001 |
Pharmacokinetic overview of Ortho Evra/Evra.
Topics: Administration, Cutaneous; Area Under Curve; Biological Availability; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Half-Life; Humans; Norgestrel; Oximes | 2002 |
Ortho Evra, a new contraceptive patch.
Topics: Administration, Cutaneous; Animals; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Humans; Norgestrel; Oximes | 2003 |
Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Topics: Administration, Cutaneous; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Drug Delivery Systems; Equipment Design; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Ethisterone; Female; Gonadal Steroid Hormones; Humans; Male; Norgestrel; Oximes; Testosterone | 2003 |
[A transdermal form of combined hormonal contraceptives (EVRA)].
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes | 2003 |
New hormonal contraceptives: a comprehensive review of the literature.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes | 2003 |
Evra--a patch on oral contraception?
Topics: Administration, Cutaneous; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Patient Compliance; Pregnancy; Randomized Controlled Trials as Topic | 2003 |
[Medication of the month. Evra: first contraceptive transdermal patch].
Topics: Administration, Cutaneous; Adult; Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Nausea; Norgestrel; Oximes; Vomiting | 2003 |
[Transdermal contraception--a new beginning].
Topics: Administration, Cutaneous; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Skin Absorption | 2004 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes | 2003 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
15 trial(s) available for norelgestromin and ethisterone
Article | Year |
---|---|
Pharmacokinetics of norelgestromin and ethinyl estradiol from two consecutive contraceptive patches.
Topics: Administration, Cutaneous; Adolescent; Adult; Area Under Curve; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Time Factors | 2001 |
Pharmacokinetics of norelgestromin and ethinyl estradiol delivered by a contraceptive patch (Ortho Evra/Evra) under conditions of heat, humidity, and exercise.
Topics: Adhesiveness; Administration, Cutaneous; Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Exercise; Female; Hot Temperature; Humans; Humidity; Middle Aged; Norgestrel; Oximes | 2001 |
Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Body Weight; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstrual Cycle; Norgestrel; Oximes; Pregnancy; Proportional Hazards Models | 2002 |
Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Female; Humans; Middle Aged; Norgestrel; North America; Oximes; Patient Compliance | 2002 |
Pharmacokinetics of a contraceptive patch (Evra/Ortho Evra) containing norelgestromin and ethinyloestradiol at four application sites.
Topics: Administration, Cutaneous; Adult; Area Under Curve; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Administration Schedule; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Humans; Middle Aged; Norgestrel; Oximes | 2002 |
Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Levonorgestrel; Norgestrel; Oximes; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
Topics: Administration, Cutaneous; Adolescent; Adult; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstrual Cycle; Middle Aged; Norgestrel; Oximes; Reference Values; Time Factors; Triglycerides | 2003 |
Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Ethisterone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medication Errors; Norgestrel; Ovarian Follicle; Ovulation; Oximes; Progesterone; Ultrasonography | 2003 |
An evaluation of the use of the transdermal contraceptive patch in adolescents.
Topics: Administration, Cutaneous; Adolescent; Analysis of Variance; Contraceptives, Oral, Combined; Drug Combinations; Ethisterone; Female; Humans; Longitudinal Studies; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; San Francisco | 2004 |
Long-term evaluation of the use of the transdermal contraceptive patch in adolescents.
Topics: Administration, Cutaneous; Adolescent; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethisterone; Female; Humans; Norgestrel; Oximes; Patient Compliance; Time | 2004 |
Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Menstruation; Middle Aged; Norgestrel; Oximes; Patient Satisfaction | 2005 |
Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Condoms; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Intrauterine Devices; Middle Aged; Norgestrel; Oximes; Patient Compliance; Patient Satisfaction; Safety; Spermatocidal Agents; Treatment Outcome | 2005 |
Suppression of estrogen-withdrawal headache with extended transdermal contraception.
Topics: Administration, Cutaneous; Adolescent; Adult; Delayed-Action Preparations; Drug Combinations; Ethisterone; Female; Headache; Humans; Middle Aged; Norgestrel; Oximes; Substance Withdrawal Syndrome; Time Factors | 2005 |
Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
Topics: Administration, Cutaneous; Adolescent; Adult; Androgens; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2005 |
[Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Women's Health | 2005 |
12 other study(ies) available for norelgestromin and ethisterone
Article | Year |
---|---|
The introduction of a transdermal hormonal contraceptive (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Progestins | 2002 |
A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Ethisterone; Female; Humans; Middle Aged; Norgestrel; Oximes; Pregnancy | 2002 |
Integrated summary of Ortho Evra/Evra contraceptive patch adhesion in varied climates and conditions.
Topics: Adhesives; Administration, Cutaneous; Adolescent; Adult; Climate; Contraceptives, Oral, Combined; Cross-Over Studies; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Ethisterone; Exercise; Female; Hot Temperature; Humans; Humidity; Middle Aged; Norgestrel; Oximes | 2002 |
Norelgestromin as selective estrogen enzyme modulator in human breast cancer cell lines. Effect on sulfatase activity in comparison to medroxyprogesterone acetate.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Ethisterone; Humans; Inhibitory Concentration 50; Medroxyprogesterone Acetate; Models, Chemical; Norgestrel; Oximes; Selective Estrogen Receptor Modulators; Sulfatases; Tumor Cells, Cultured | 2003 |
New drugs 2003, part II.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Approval; Drug Combinations; Drug Therapy; Epoprostenol; Estradiol; Ethisterone; Filgrastim; Fondaparinux; Fulvestrant; Granulocyte Colony-Stimulating Factor; Humans; Norgestrel; Oximes; Polyethylene Glycols; Polysaccharides; Recombinant Proteins; Triptorelin Pamoate; United States; Vinyl Compounds | 2003 |
New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Device Approval; Drug Combinations; Estrogens; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; United Kingdom; Women's Health | 2004 |
Matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression is not regulated by norgestimate or norelgestromin.
Topics: 17-alpha-Hydroxyprogesterone; Cell Line, Tumor; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Endometrium; Enzyme-Linked Immunosorbent Assay; Estradiol; Ethisterone; Female; Humans; Matrix Metalloproteinase 2; Norgestrel; Oximes; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2004 |
[Hormonal contraceptive patch].
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Risk Factors | 2004 |
Induction of androgen receptor activity by norgestimate and norelgestromin in MDA-MB 231 breast cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Breast Neoplasms; Contraceptives, Oral, Combined; Dihydrotestosterone; Drug Combinations; Ethisterone; Genetic Vectors; Humans; Luciferases; Norgestrel; Oximes; Receptors, Androgen; Testosterone; Transfection; Tumor Cells, Cultured | 2004 |
Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
Topics: Abdomen; Acne Vulgaris; Administration, Cutaneous; Adolescent; Attitude to Health; Breast; Buttocks; Condoms; Contraceptives, Oral, Combined; Drug Carriers; Drug Combinations; Dysmenorrhea; Ethisterone; Female; Headache; Humans; Menstrual Cycle; Menstruation; Nausea; Norgestrel; Oximes; Patient Dropouts; Patient Satisfaction | 2005 |
The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns.
Topics: Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; United States; United States Food and Drug Administration | 2006 |
How should we advise patients about the contraceptive patch, given the FDA warning?
Topics: Contraceptives, Oral, Combined; Counseling; Drug Combinations; Drug Utilization; Ethisterone; Female; Humans; Norgestrel; Oximes; Physician-Patient Relations; Practice Patterns, Physicians'; Risk Assessment; United States; United States Food and Drug Administration; Venous Thrombosis | 2006 |